Yuka Tanaka1, Michihide Tokuhira1, Takayuki Tabayashi1, Yasuyuki Takahashi1, Yuta Kimura1, Tatsuki Tomikawa1, Junichi Watanabe1, Tomoe Anan1, Morihiko Sagawa1, Reiko Nakaseko1, Shuji Momose2, Jun-Ichi Tamaru2, Masahiro Kizaki1 (1.Department of Hematology, Saitama Medical Center, Saitama Medical University, Japan, 2.Department of Pathology, Saitama Medical Center, Saitama Medical University, Japan)
Session information
Poster Session
Sun. Oct, 14
Poster Session 3-16 DLBCL: Prognostic factors
Sun. Oct 14, 2018 1:00 PM - 1:40 PM Poster2 (Osaka International Convention Center, 5F Main Foyer)
Chair: Hideki Tsujimura (Chiba Cancer Center)
Rika Sakai1, Hirotaka Takasaki1, Ayumi Numata1, Megumi Koyama1, Hideki Arakai1, Kenji Motohashi1, Takayuki Sakuma1, Hideaki Nakajima2 (1.Medical Oncol., Kanagawa Cancer Center, Yokohama, Japan, 2.Hematol. and Clinical Immunol, Yokohama City University School of Medicine)
Shinji Ogura, Masahiro Akimoto, Kyoko Masuda, Takahiro Kamiya, Kota Mizuno, Chisako Ito, Yuriko Fujita, Yoshinobu Aisa, Tomonori Nakazato (Department of Hematology, Yokohama Municipal Citizen's Hospital)
[PS3-16-4] Serum sIL-2R level is a prognostic stratification marker of diffuse large B-cell lymphoma
Satoshi Ichikawa1, Noriko Fukuhara1, Masahiro Kobayashi1, Yoko Okitsu1, Yasushi Onishi1, Ryo Ichinohasama2, Kenichi Ishizawa3, Hideo Harigae1 (1.Hematol. and Rheumatol., Tohoku Univ., Sendai, 2.Hematopathol. Tohoku Univ., Sendai, 3.Hematol. and Cell Therapy, Yamagata Univ., Yamagata.)
Shinichiro Matsui, Shintaro Izumi, Yuri Kawashima, Ayako Nakamura, Hironori Arai, Yoshikazu Utsu, Reiko Nakaseko, Shinichi Masuda, Nobuyuki Aotsuka (Department of Hematology Oncology, Japanese Red Cross Narita Hospital)
Ryo Ueda, Aki Sakurai, Kyoko Itakusu, Yukihiro Miyazaki, Koichi Nakase, Yuichiro Nawa (Division of Hematol., Ehime Prefectural central hospital, Ehime, Japan)
Koh Izumiyama1, Koichiro Minauchi2, Hajime Senjo1,2, Reiki Ogasawara1, Minoru Kanaya1, Akio Mori1, Takeshi Kondo1, Makoto Saito1, Masanori Tanaka1, Masanobu Morioka1 (1.Dept. Hematol., Aiiku Hospital, Sapporo, Japan, 2.Dept., Hematol., Sapporo Hokuyu Hospital, Sapporo, Japan)
Yuko Mishima1, Masahiro Yokoyama1, Noriko Nishimura1, Yoshiharu Kusano1, Norihito Inoue1, Anna Nishihara1, Naoko Tsuyama2, Kengo Takeuchi2,3, Kiyohiko Hatake4, Yasuhito Terui1 (1.Dept of Hematology Oncology, The Cancer Institute Hospital, JFCR, 2.Div. of Pathology, The Cancer Institute Hospital, JFCR, 3.Pathology Project for Molecular Targets of The Cancer Institute, JFCR, 4.International University of Health and Welfare, Mita Hospital)